National Bank of Canada’s Novartis NVS Stock Holding History

National Bank of Canada’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.33M	Buy	47,991 +3,580	+8%	+$549K	0.01%	770
2025 Q4	$6.12M	Buy	44,411 +5,042	+13%	+$660K	0.01%	838
2025 Q3	$5.05M	Sell	39,369 -31,835	-45%	-$3.88M	0.01%	881
2025 Q2	$8.69M	Buy	71,204 +23,733	+50%	+$2.67M	0.01%	819
2025 Q1	$5.27M	Sell	47,471 -81,436	-63%	-$8.67M	0.01%	884
2024 Q4	$12.5M	Buy	128,907 +12,009	+10%	+$1.28M	0.01%	699
2024 Q3	$13.4M	Sell	116,898 -61,102	-34%	-$6.93M	0.02%	591
2024 Q2	$18.9M	Buy	178,000 +31,812	+22%	+$3.19M	0.03%	401
2024 Q1	$14.9M	Buy	146,188 +5,104	+4%	+$523K	0.02%	509
2023 Q4	$14.3M	Buy	141,084 +1,220	+0.9%	+$118K	0.02%	490
2023 Q3	$14.1M	Buy	139,864 +4,605	+3%	+$467K	0.02%	508
2023 Q2	$13.6M	Buy	135,259 +1,814	+1%	+$181K	0.02%	469
2023 Q1	$12.2M	Sell	133,445 -11,776	-8%	-$1.03M	0.03%	387
2022 Q4	$13.2M	Buy	145,221 +1,022	+0.7%	+$86.1K	0.03%	362
2022 Q3	$10.9M	Buy	144,199 +6,990	+5%	+$579K	0.06%	339
2022 Q2	$11.6M	Buy	137,209 +11,526	+9%	+$1.01M	0.05%	361
2022 Q1	$10.9M	Sell	125,683 -21,912	-15%	-$1.9M	0.03%	429
2021 Q4	$12.9M	Buy	+147,595	New	+$12.3M	0.04%	329

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

National Bank of Canada's NVS Position: Q1 2026 in Review

National Bank of Canada increased its Novartis (NVS) stake by 8.1% in Q1 2026, buying an estimated $549K and bringing the position to 47,991 shares worth $7.33M. The position accounts for 0.01% of the portfolio, ranked #770.

National Bank of Canada first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $18.9M in Q2 2024. 1,594 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

National Bank of Canada held 47,991 shares of Novartis worth $7.33M as of Q1 2026.
National Bank of Canada bought 3,580 Novartis shares in Q1 2026, an estimated $549K.
Novartis made up 0.01% of National Bank of Canada's portfolio in Q1 2026, its #770 holding.
National Bank of Canada first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's Novartis position peaked at $18.9M in Q2 2024.
1,594 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.